This has been corroborated by literature illustrating mRNA for GHRH peptides, as well as mRNA for the GHRH-R and up to four different splice variants, SV1 being the most common form, both in vitro and in vivo across multiple cancer models [47]. This evidence concerns the gene GHRH and cancer.